News
In an interview, Dr. Rosario Ligresti highlighted what patients with gastrointestinal stromal tumors, or GIST, should know ...
The GIST treatment landscape has shifted in recent years due to the emergence of new therapies, many of which patients should ...
I share how my daughter’s cancer team let me stay involved and supported, helping me remain present as her mom through every step of treatment.
The FDA declined approval of Darzalex Faspro for newly diagnosed, transplant-ineligible multiple myeloma in its current form.
CURE spoke with an expert about the needs of children in families living with cancer during back-to-school season.
The FDA approved the Dako Omnis panel to identify patients with colorectal cancer with mismatch repair deficiency.
Being diagnosed with a disease like prostate cancer is a very impactful life event, making it vital to have people you love ...
Through cancer treatment, loss, as well as many life changes, I found healing in simple moments of community and laughter ...
CAR-T cell therapies are now being explored for the treatment of solid tumors like gliomas, Dr. Tanja A. Gruber explained in ...
The FDA granted breakthrough therapy designation to Ifinatamab deruxtecan for some with extensive-stage small cell lung ...
Kimberly (Cary) Demirhan, a registered nurse and assistant director of Education Programs at the Association of Cancer Care Centers (ACCC), sat down for an interview with CURE to discuss the need for ...
Study finds anti-nausea drug aprepitant boosts distant disease-free and breast cancer-specific survival in early-stage triple ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results